Nature Communications · 2023 · 18 citations · 40 references
Life SciencesBiochemistryPharmacologyCellular MetabolismMetabolic RegulationMetabolismDiabetes MellitusGlucose HomeostasisGlycemic ControlLipid MetabolismPentose Phosphate PathwayPentose Phosphate Pathway RegulationDiabetes Mellitus PathophysiologyGlucose Transport RegulationLipid Peroxidation ResistancePentose Phosphate Pathway FluxProtein Phosphatase 2A RegulationProtein Phosphatase CatalysisSphingosine 1-Phosphate SignalingSphingosine-1-phosphate Signaling
Red blood cells (RBC) are the major carriers of sphingosine-1-phosphate (S1P) in blood. Here we show that variations in RBC S1P content achieved by altering S1P synthesis and transport by genetic and pharmacological means regulate glucose uptake and metabolic flux. This is due to S1P-mediated activation of the catalytic protein phosphatase 2 (PP2A) subunit leading to reduction of cell-surface glucose transporters (GLUTs). The mechanism dynamically responds to metabolic cues from the environment by increasing S1P synthesis, enhancing PP2A activity, reducing GLUT phosphorylation and localization, and diminishing glucose uptake in RBC from diabetic mice and humans. Functionally, it protects RBC against lipid peroxidation in hyperglycemia and diabetes by activating the pentose phosphate pathway. Proof of concept is provided by the resistance of mice lacking the S1P exporter MFSD2B to diabetes-induced HbA1c elevation and thiobarbituric acid reactive substances (TBARS) generation in diabetic RBC. This mechanism responds to pharmacological S1P analogues such as fingolimod and may be functional in other insulin-independent tissues making it a promising therapeutic target.
40
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Susan R. Schwab, João P. Pereira, Mehrdad Matloubian et al. · Science · 2005 · 783 citations
The Ubiquitous Glucose Transporter GLUT-1 Is a Receptor for HTLV
Nicolas Manel, Felix J. Kim, Sandrina Kinet et al. · Cell · 2003 · 453 citations · Full text
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
Steven W. Paugh, Shawn G. Payne, Suzanne E. Barbour et al. · FEBS Letters · 2003 · 305 citations